Company page

Definium Therapeutics, Inc.

Definium Therapeutics, Inc. (Ticker: DFTX) is a public company based in the United States, with a market capitalization of approximately $5.73 billion. The company is focused on developing innovative therapeutic solutions. As a publicly traded entity, Definium Therapeutics is listed on the American market, providing investors with opportunities to engage with its growth and advancements in the healthcare sector.